Company Filing History:
Years Active: 2020-2023
Title: Innovations of Heng Liang Tan in Antigen-Binding Proteins
Introduction
Heng Liang Tan is a notable inventor based in Singapore, SG. He has made significant contributions to the field of biotechnology, particularly in the development of antigen-binding proteins. With a total of 3 patents, his work has the potential to impact therapeutic applications in cancer treatment.
Latest Patents
One of Heng Liang Tan's latest patents is focused on anti-annexin A2 monoclonal antibodies. This invention relates to an antigen-binding protein that includes specific amino acid sequences in both heavy and light chain variable domains. The patent also covers compositions and methods of use for these proteins, which could be crucial in medical applications. Another significant patent involves anti-ERBB-2 antibodies, which are designed to bind to the ERBB2 protein. This invention includes methods for detecting cancer and provides kits for practical use in clinical settings.
Career Highlights
Heng Liang Tan is affiliated with the Agency for Science, Technology and Research, where he continues to advance his research in biotechnology. His work is characterized by a strong focus on developing innovative solutions for medical challenges.
Collaborations
Heng Liang Tan collaborates with esteemed colleagues such as Andre Boon Hwa Choo and Simeon Cua. Their combined expertise enhances the research and development efforts in their field.
Conclusion
Heng Liang Tan's contributions to the field of antigen-binding proteins demonstrate his commitment to innovation in biotechnology. His patents reflect a dedication to advancing medical science and improving therapeutic options for patients.